Department of Psychiatry and Psychotherapy Bethel, Ev. Hospital Bielefeld, Bielefeld, Germany.
Psychoneuroendocrinology. 2010 Feb;35(2):316-20. doi: 10.1016/j.psyneuen.2009.06.015. Epub 2009 Jul 19.
Overgeneral autobiographical memory has become a well established phenomenon within major depressive disorder (MDD). Neuroendocrinologically, MDD is often characterized by a dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, i.e. hypercortisolemia and reduced feedback sensitivity. In healthy participants cortisol administration has been found to impair autobiographical memory retrieval. The purpose of this study was to compare the effects of acute cortisol administration on autobiographical memory in MDD patients with the effects observed in healthy controls. We hypothesized that in contrast to healthy control subjects acute cortisol administration would not affect autobiographical memory performance in MDD due to reduced central glucocorticoid sensitivity.
In a placebo-controlled, double-blind crossover study, 16 patients with MDD and 16 healthy control subjects received a placebo or 10mg of hydrocortisone orally before autobiographical memory testing (AMT).
In the placebo condition depressed patients performed poorer than controls. After hydrocortisone intake, healthy subjects reported significantly fewer specific memories on the AMT compared to placebo treatment. In contrast, memory specificity of MDD patients was not affected by hydrocortisone treatment.
The present findings replicate previous findings of impaired autobiographical memory retrieval after hydrocortisone treatment in healthy subjects and of impaired AMT performance in depressed patients. We speculate that the missing acute impairing effect of hydrocortisone on autobiographical memory in depressed patients might reflect reduced central glucocorticoid sensitivity. However alternative explanations cannot be ruled out.
在重度抑郁症(MDD)中,过度概括自传体记忆已成为一种既定现象。神经内分泌学上,MDD 常表现为下丘脑-垂体-肾上腺(HPA)轴失调,即皮质醇过多和反馈敏感性降低。在健康参与者中,皮质醇给药已被发现会损害自传体记忆检索。本研究的目的是比较急性皮质醇给药对 MDD 患者和健康对照组的自传体记忆的影响。我们假设,与健康对照组相比,由于中枢糖皮质激素敏感性降低,急性皮质醇给药不会影响 MDD 患者的自传体记忆表现。
在一项安慰剂对照、双盲交叉研究中,16 名 MDD 患者和 16 名健康对照者在自传体记忆测试(AMT)前口服安慰剂或 10mg 氢可酮。
在安慰剂条件下,抑郁患者的表现不如对照组。在接受氢化可的松摄入后,与安慰剂治疗相比,健康受试者在 AMT 上报告的特定记忆明显减少。相比之下,MDD 患者的记忆特异性不受氢化可的松治疗的影响。
本研究结果复制了先前在健康受试者中发现的氢化可的松治疗后自传体记忆检索受损以及抑郁患者 AMT 表现受损的研究结果。我们推测,在抑郁患者中,氢化可的松对自传体记忆的急性损害作用缺失可能反映了中枢糖皮质激素敏感性降低。然而,不能排除其他解释。